The Swedish medtech company RLS Global completes a directed new share issue, raising proceeds of SEK 50 million before transaction costs. 

The investors in the new share issue are a number of Swedish and international institutional investors, which have been selected based on an accelerated bookbuilding procedure.

RLS Global offers products and methods for treating wounds and dental diseases.

Pareto Securities AB is acting Sole Bookrunner and Baker McKenzie is legal adviser to RLS Global in connection with the directed new share issue. Baker McKenzie’s team mainly consists of Joakim Falkner and Ian Gulam.
Explore Our Newsroom